BOEHRINGER INGELHEIM INTERNATIONAL GMBH;VITAE PHARMACEUTICALS, INC.
发明人:
申请号：
EP09788981.0
公开号：
EP2324018B1
申请日:
2009.07.23
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
This invention relates to novel compounds of the Formula lm 1 , pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 ²-HSD1 in mammals.
